An Act relative to preventing overdose deaths and increasing access to treatment
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This bill aims to reduce overdose deaths and improve access to treatment for substance use disorders in Massachusetts. It seeks to expand access to harm reduction services, such as naloxone distribution and syringe exchange programs, and increase the availability of medication-assisted treatment options. The legislation also intends to support individuals struggling with substance use through various support services and programs. Ultimately, the goal is to prevent overdose deaths and provide comprehensive care for those in need.
Key provisions
- Expands access to naloxone distribution programs.
- Supports the implementation of syringe exchange programs.
- Increases access to medication-assisted treatment for substance use disorders.
- Provides funding for harm reduction services.
- Supports comprehensive support services for individuals with substance use disorders.
- Encourages collaboration between healthcare providers and community organizations.
- Addresses barriers to treatment access.
- Promotes evidence-based practices in overdose prevention and treatment.
Who is affected
- Individuals struggling with substance use disorders
- Families affected by substance use disorders
- Healthcare providers
- Community organizations
- Public health officials
Notable changes
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
39 on record
Primary sponsor
Cosponsors
Amy Mah Sangiolo
Antonio F. D. Cabral
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours